PanGen Biotech Overview

  • Founded
  • 1999
Founded
  • Status
  • Public
  • Employees
  • 77
Employees
  • Stock Symbol
  • 222110
Stock Symbol
  • Share Price
  • $8.55
  • (As of Friday Closing)

PanGen Biotech General Information

Description

Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
KRX
Primary Office
  • 4th Floor, Innoplex 2-dong
  • 306 Sinwon-ro, Yeongtong-gu
  • Suwon-si, Gyeonggi
  • South Korea
+82 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PanGen Biotech Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.55 $8.71 $3.26 - $11.75 $82.5M 9.6M 91.6K -$0.38

PanGen Biotech Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
Revenue 5,244 5,244 2,471 5,167
EBITDA (1,720) (1,720) (5,648) (568)
Net Income (3,689) (3,689) (7,665) (4,213)
Total Assets 33,283 33,283 33,740 40,785
Total Debt 16,865 16,865 15,009 14,461
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PanGen Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PanGen Biotech‘s full profile, request access.

Request a free trial

PanGen Biotech Executive Team (2)

Name Title Board Seat Contact Info
Jaeseung Yoon Ph.D Co-Founder, Co-President & Co-Chief Executive Officer
Youngboo Kim Co-President & Chief Executive Officer
To view PanGen Biotech’s complete executive team members history, request access »

PanGen Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PanGen Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PanGen Biotech‘s full profile, request access.

Request a free trial